Amgen Inc (NASDAQ:AMGN) Stock Price Up as Sentiment Increases

Amgen Inc. (NASDAQ:AMGN) Logo

Sentiment for Amgen Inc (NASDAQ:AMGN)

Amgen Inc (NASDAQ:AMGN) institutional sentiment increased to 0.99 in 2019 Q2. Its up 0.11, from 0.88 in 2019Q1. The ratio increased, as 548 active investment managers started new or increased positions, while 551 sold and decreased positions in Amgen Inc. The active investment managers in our partner’s database now have: 442.30 million shares, down from 457.12 million shares in 2019Q1. Also, the number of active investment managers holding Amgen Inc in their top 10 positions decreased from 45 to 38 for a decrease of 7. Sold All: 66 Reduced: 485 Increased: 428 New Position: 120.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company has market cap of $117.06 billion. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. It has a 15.5 P/E ratio. The companyÂ’s products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism ; and Erenumab for the prevention of migraine.

The stock increased 0.61% or $1.19 during the last trading session, reaching $195.19. About 1.67 million shares traded. Amgen Inc. (NASDAQ:AMGN) has declined 2.12% since September 13, 2018 and is downtrending. It has underperformed by 2.12% the S&P500.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on October, 29. They expect $3.46 earnings per share, down 6.23 % or $0.23 from last year’s $3.69 per share. AMGN’s profit will be $2.07B for 14.10 P/E if the $3.46 EPS becomes a reality. After $3.97 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts -12.85 % negative EPS growth.

Krensavage Asset Management Llc holds 12.88% of its portfolio in Amgen Inc. for 215,402 shares. Smead Capital Management Inc. owns 646,099 shares or 5.73% of their US portfolio. Moreover, Tekla Capital Management Llc has 5.49% invested in the company for 729,658 shares. The New York-based Valueworks Llc has invested 4.99% in the stock. Coho Partners Ltd., a Pennsylvania-based fund reported 1.11 million shares.

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

Ratings analysis reveals 50% of Amgen Inc’s analysts are positive. Out of 10 Wall Street analysts rating Amgen Inc, 5 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $19800 while the high is $24000. The stock’s average target of $215.50 is 10.41% above today’s ($195.19) share price. AMGN was included in 14 notes of analysts from March 14, 2019. RBC Capital Markets maintained the shares of AMGN in report on Tuesday, August 27 with “Sector Perform” rating. The firm has “Overweight” rating by Morgan Stanley given on Monday, July 15. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Mizuho on Friday, June 21. The rating was maintained by Oppenheimer on Tuesday, August 13 with “Outperform”. The rating was maintained by BMO Capital Markets with “Outperform” on Tuesday, August 27. The firm earned “Neutral” rating on Thursday, August 29 by JP Morgan. The stock has “Neutral” rating by Mizuho on Monday, August 19. The stock has “Neutral” rating by Cantor Fitzgerald on Thursday, September 5. As per Thursday, March 14, the company rating was initiated by BMO Capital Markets. The rating was maintained by Wells Fargo on Monday, August 12 with “Market Perform”.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Health Care Sector Update for 08/28/2019: PAHC, LCI, SNGX, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” on August 28, 2019, also Nasdaq.com with their article: “Noteworthy Monday Option Activity: YUM, AMGN, EVRI – Nasdaq” published on September 09, 2019, Nasdaq.com published: “Should Value Investors Choose Amgen (AMGN) Stock Now? – Nasdaq” on August 13, 2019. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Nasdaq.com and their article: “Top Ranked Momentum Stocks to Buy for August 26th – Nasdaq” published on August 26, 2019 as well as Nasdaq.com‘s news article titled: “Nasdaq 100 Movers: AMGN, NFLX – Nasdaq” with publication date: September 09, 2019.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.